Shay Levav
CIK: 0002047217
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ICCM
IceCure Medical Ltd.
Officer
Discretionary Trading P&L
Holdings
About Levav Shay
Levav Shay (SEC CIK 0002047217) files insider reports with the SEC as Chief Operating Officer of IceCure Medical Ltd. (ICCM).
Signal8 holds 2 ownership filings by Levav Shay (1 Form 3, 1 Form 4), filed between Mar 25, 2026 and Aug 17, 2026. Those filings report 1 transaction, the latest on Aug 14, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Levav Shay's filings is in CAESAREA.
Recent filings by Levav Shay
- Aug 14, 2026: Grant or award of ICCM shares (Form 4, code A).
Other insiders filing for IceCure Medical Ltd. (ICCM)
- Shamir Eyal, Chief Executive Officer
- Mayron Ron, Director
- Good Shad, VP, Sales for North America
- Salton David, Director
- Tel-Tzure Tlalit Bussi, VP, BD & Global Marketing
- Dotan Merav Nir, VP, Human Resources